All AKLIDES® ANCA kits

All AKLIDES kits based on tissue sections

All AKLIDES kits based on CytoBead Technology

All CytoBead®

Crohn's disease-related products (ASCA and anti-GP2)

All DotDiver kits

All ANCA Kits (IFA, Blot, ELISA)

Our portfolio of cutting‑edge diagnostic solutions combines automated analyzers, advanced immunoassays and modern laboratory technologies. From digital benchtop IFA analyzers and automated LINE/Dot / Blot systems to robust immunoassays and ready-to-use reagents  we deliver efficient tools that support precise diagnostics and streamline lab workflows.

Built for clinical laboratories, diagnostic centers and medical professionals, our solutions deliver reliable, reproducible results  helping you make informed clinical decisions quickly and confidently.

Our immunofluorescence assays (IFA) deliver precise and reliable diagnostics for medical laboratories and research institutions. They use state-of-the-art technology to ensure high sensitivity, specificity, and ease of use.

Whether in automated systems or manual testing, our IFA solutions detect specific antibodies against skin antigens quickly and reliably. This approach increases efficiency and strengthens the diagnostic value of your results.

Our test systems and assays empower laboratories to uncover and monitor autoimmune diseases with precision. They cover key areas such as the thyroid, joints, connective tissue, gastrointestinal tract, liver, kidneys, and nervous system.

We provide assays in ELISA, IFA, RIA, Line/DOT, and rapid lateral-flow formats, suitable for both manual and automated workflows. With validated reagents and standardized procedures, laboratories can achieve consistent, reliable, and accurate results, enabling confident diagnoses and better patient care.

From Enzyme-Linked Immunosorbent Assay (ELISA) and Radioimmuno Assays (RIA) to Immunofluorescence Assays (IFA), Lateral Flow tests, and LINE & Dot (Immunoblot) assays, we provide both manual and automatable medical test kits as well as fully automated diagnostic systems. Each method is designed to deliver maximum precision, reliability, and efficiency in laboratory diagnostics. Our solutions empower medical laboratories, physicians, and research institutions around the globe to achieve accurate diagnoses and improved patient outcomes.

Systemic lupus erythematosus (SLE) is a complex autoimmune disease. The immune system attacks healthy cells, causing inflammation in multiple organs. Antinuclear autoantibodies play a central role in diagnosis and monitoring disease activity.

Our diagnostic portfolio covers the full spectrum of SLE testing. This includes highly sensitive immunofluorescence assays (IFA) such as nDNA IFA plus and AKLIDES® nDNA for anti-dsDNA antibodies, quantitative anti-dsDNA assays, and qualitative or semi-quantitative dot and line immunoassays. Laboratories can reliably detect diverse autoantibody profiles.

The assays support differentiation of SLE from other autoimmune and rheumatologic disorders. Our solutions deliver fast, reproducible, and clinically meaningful results, enabling laboratories and research institutions to perform accurate diagnostics and support informed therapeutic decisions.

Systemic vasculitis and immune-mediated renal diseases require structured and highly reliable serological testing. Inflammatory vascular damage and glomerular involvement may progress rapidly and demand precise antibody assessment.

Our portfolio covers the full spectrum of ANCA and anti-GBM diagnostics. We combine classical immunofluorescence assays on ethanol- and formalin-fixed neutrophils with advanced IFA-plus formats, dual slides, and fully automated AKLIDES® systems.

CytoBead® technology integrates pattern recognition and antigen-specific differentiation including PR3, MPO, GBM, and dsDNA — within a single streamlined workflow.

Qualitative dot and line immunoassays, as well as quantitative PR3 and MPO assays, further expand diagnostic capabilities and support both screening and disease monitoring.

Our solutions deliver standardized, sensitive, and clinically meaningful results from ANCA pattern detection to precise antigen identification in ANCA-associated vasculitis, RPGN, and Goodpasture syndrome.